Evidence map›Paper›PMID 36551248›Full record

ReviewBiomolecules2022

Secondary Metabolites Diversity of

Levy Tenório Sousa Domingos, Raquel Dos Santos Martins, Leonardo Melo de Lima, Angela Michelato Ghizelini, Antonio Ferreira-Pereira, Fernando Cotinguiba

Abstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. From Mushrooms to Molecules: Exploring Depsidones inMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Two Novel Compounds Isolated from the Marine Fungal Symbiont ofJournal of experimental pharmacology · 2025
    Article
  9. Article
  10. Article
  11. Nornidulin, A New Inhibitor ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Levy Tenório Sousa DomingosInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 21941-902, Brazil.ORCID 0000-0002-9970-3683
Raquel Dos Santos MartinsInstituto de Pesquisas de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Bloco H, Cidade Universitária, Rio de Janeiro CEP 21941-902, Brazil.
Leonardo Melo de LimaInstituto de Pesquisas de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Bloco H, Cidade Universitária, Rio de Janeiro CEP 21941-902, Brazil.
Angela Michelato GhizeliniInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 21941-902, Brazil.
Antonio Ferreira-PereiraInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 21941-902, Brazil.ORCID 0000-0002-0474-8388
Fernando CotinguibaInstituto de Pesquisas de Produtos Naturais Walter Mors, Universidade Federal do Rio de Janeiro, Avenida Carlos Chagas Filho, 373, Bloco H, Cidade Universitária, Rio de Janeiro CEP 21941-902, Brazil.ORCID 0000-0002-7006-0768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsAspergillusAnimalsAnti-Bacterial AgentsModels, MolecularAnti-Bacterial AgentsAnti-Infective Agentsbioactive natural productsdepsidesdepsidonesfungi metabolites

Identifiers

PMID36551248
PMCPMC9775040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.